Oestradiol Contributes to Differential Antitumour Effects of Adjuvant Zoledronic Acid Observed Between Pre- and Post-Menopausal Women.

Front Endocrinol (Lausanne) · 2021 · PMC8559775 · PMID 34733240

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Mice from a BALB/c background showed a trend toward reduced bone metastasis following administration of Zol, and this was independent of oestradiol concentrations, a functional adaptive immune system, or tumour (human MDA-MB-231 or mouse 4T1).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.